Publications by authors named "Sherouk Fouda"

Claim this Profile
T
Tailoring dual antiplatelet therapy for stroke prevention: a meta-analysis of timing, duration, regimen, and stroke subtypes.
Naif M Alhawiti, Sherouk Fouda, Naser D Alotaibi, Hassan A Madkhali, Fahad K Alsharef

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Aspirin and Clopidogrel among Patients with Chronic Obstructive Lung Disease: Insights from a Meta-Analysis.
Naif M Alhawiti, Taha T Ismaeil, Sherouk Fouda, Badi A Alotaibi, Ashraf El-Metwally

J Clin Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic-associated fatty liver disease and sarcopenia: A double whammy.
Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez, Joseph M Pappachan

World J Hepatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathobiology of Metabolic-Associated Fatty Liver Disease.
Sherouk Fouda, Mohammed Sadiq Jeeyavudeen, Joseph M Pappachan, Venkataraman Jayanthi

Endocrinol Metab Clin North Am· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic-Associated Fatty Liver Disease: A Disastrous Human Health Challenge.
Sherouk Fouda, Joseph M Pappachan

Endocrinol Metab Clin North Am· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of metabolic-associated fatty liver disease: The diabetology perspective.
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, Joseph M Pappachan

World J Gastroenterol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.
Mohammad Sadiq Jeeyavudeen, Rahul Chaudhari, Joseph M Pappachan, Sherouk Fouda

World J Gastroenterol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update.
Sherouk Fouda, Madhu Mathew Vennikandam, Joseph M Pappachan, Cornelius J Fernandez

J Clin Transl Hepatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to cigarette smoke precipitates simple hepatosteatosis to NASH in high-fat diet fed mice by inducing oxidative stress.
Sherouk Fouda, Anwar Khan, Stanley M H Chan, Ali Mahzari, Xiu Zhou

Clin Sci (Lond)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic complications of hepatitis C virus infection.
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan

World J Gastroenterol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease.
Xiu Zhou, Sherouk Fouda, Dongli Li, Kun Zhang, Ji-Ming Ye

Nutrients· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cigarette smoking blocks the benefit from reduced weight gain for insulin action by shifting lipids deposition to muscle.
Anwar Khan, Sherouk Fouda, Ali Mahzari, Stanley M H Chan, Xiu Zhou

Clin Sci (Lond)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome.
Xiu Zhou, Sherouk Fouda, Xiao-Yi Zeng, Dongli Li, Kun Zhang

Front Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrine Protects Against MCD-Induced Development of NASH via Upregulating HSP72 and Downregulating mTOR in a Manner Distinctive From Metformin.
Ali Mahzari, Songpei Li, Xiu Zhou, Dongli Li, Sherouk Fouda

Front Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preconditioning lessens high fat induced metabolic syndrome along with markers of increased metabolic capacity in muscle and adipose tissue.
Songpei Li, Xiu Zhou, Eunjung Jo, Ali Mahzari, Sherouk Fouda

Biosci Rep· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis